CN102533740B - 人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 - Google Patents
人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 Download PDFInfo
- Publication number
- CN102533740B CN102533740B CN 201110264119 CN201110264119A CN102533740B CN 102533740 B CN102533740 B CN 102533740B CN 201110264119 CN201110264119 CN 201110264119 CN 201110264119 A CN201110264119 A CN 201110264119A CN 102533740 B CN102533740 B CN 102533740B
- Authority
- CN
- China
- Prior art keywords
- abl
- pcr
- primer
- bcr
- fusion gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110264119 CN102533740B (zh) | 2011-09-07 | 2011-09-07 | 人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110264119 CN102533740B (zh) | 2011-09-07 | 2011-09-07 | 人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102533740A CN102533740A (zh) | 2012-07-04 |
CN102533740B true CN102533740B (zh) | 2013-07-24 |
Family
ID=46341772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110264119 Active CN102533740B (zh) | 2011-09-07 | 2011-09-07 | 人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102533740B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103555827A (zh) * | 2013-09-27 | 2014-02-05 | 上海艾迪康医学检验所有限公司 | 检测bcr/abl融合基因abl激酶区耐药突变位点的引物、方法和试剂盒 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103045590A (zh) * | 2012-12-26 | 2013-04-17 | 武汉康圣达医学检验所有限公司 | 引物及该引物检测bcr/abl融合基因abl激酶区耐药突变位点的方法 |
CN103013994A (zh) * | 2012-12-26 | 2013-04-03 | 武汉康圣达医学检验所有限公司 | 引物及该引物筛选9种已知bcr/abl融合基因方法 |
CN103571945B (zh) * | 2013-09-27 | 2015-05-06 | 沈阳艾迪康医学检验所有限公司 | 筛查和鉴定bcr-abl非常见融合型别的方法、引物、探针和试剂盒 |
JP6531312B2 (ja) * | 2014-10-17 | 2019-06-19 | 東洋鋼鈑株式会社 | Bcr−abl阻害剤耐性関連変異の検出方法及びこれを用いたbcr−abl阻害剤耐性を予測するためのデータ取得方法 |
CN104630343A (zh) * | 2014-12-05 | 2015-05-20 | 中国人民解放军第四军医大学 | 一种快速检测慢性粒细胞白血病bcr/abl融合基因及其剪切突变体的方法 |
CN105838793B (zh) * | 2016-04-22 | 2019-07-12 | 上海荻硕贝肯生物科技有限公司 | 用于定性检测白血病融合基因的引物、试剂盒及方法 |
CN111808959A (zh) * | 2020-07-17 | 2020-10-23 | 杭州艾迪康医学检验中心有限公司 | 检测tcf3-hlf融合基因的引物和方法 |
CN112501301B (zh) * | 2020-12-08 | 2023-07-18 | 凯杰生物工程(深圳)有限公司 | 一种用于定量检测bcr-abl融合基因的引物和探针组合、试剂盒及其使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2241636A1 (en) * | 2002-03-13 | 2010-10-20 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
CN101984071B (zh) * | 2010-09-21 | 2013-01-16 | 广州益善生物技术有限公司 | 一种Bcr-Abl基因突变检测液相芯片 |
-
2011
- 2011-09-07 CN CN 201110264119 patent/CN102533740B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103555827A (zh) * | 2013-09-27 | 2014-02-05 | 上海艾迪康医学检验所有限公司 | 检测bcr/abl融合基因abl激酶区耐药突变位点的引物、方法和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN102533740A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102533740B (zh) | 人白血病融合基因bcr-abl的rt-pcr引物及其使用方法 | |
Beltran et al. | Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity | |
CN102719525B (zh) | 用于检测eml4-alk融合基因突变的引物、探针及检测试剂盒 | |
CN102177251B (zh) | 恶性神经胶质瘤的异柠檬酸脱氢酶和其他基因的遗传改变 | |
ES2897953T3 (es) | Procedimientos de diagnóstico y tratamiento del síndrome de Tourette | |
EP2691538A1 (en) | Markers associated with cyclin-dependent kinase inhibitors | |
US11118232B2 (en) | Methods of detecting DDR2 mutations | |
CN103114133A (zh) | 一种用于检测c-kit基因突变的探针、引物及检测试剂盒 | |
CN101608240A (zh) | 用于检测人类egfr基因突变的引物、探针及其使用方法 | |
JP6531312B2 (ja) | Bcr−abl阻害剤耐性関連変異の検出方法及びこれを用いたbcr−abl阻害剤耐性を予測するためのデータ取得方法 | |
CN102776286B (zh) | 用于检测ros1基因融合突变的引物、探针及检测试剂盒 | |
KR101988100B1 (ko) | 소변 엑소좀 유래 바이러스 miRNA를 이용한 BK 바이러스 신병증 진단 기술 | |
Künstlinger et al. | High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors | |
CN102206702A (zh) | miR-122作为肝脏疾病血清标志物 | |
CN103667269B (zh) | 用于与bcr或abl基因杂交的dna探针库及采用其富集bcr-abl基因片段的方法 | |
CN105256036A (zh) | 一种检测血清中lncARSR的试剂盒及其在检测肾癌舒尼替尼耐药中的应用 | |
CN103290120B (zh) | 一种用于检测alk基因表达的探针、引物及试剂盒 | |
CN103820545A (zh) | 用于检测人abcg2基因突变的探针、引物及试剂盒 | |
CN109971832A (zh) | 一种检测基因突变的试剂盒、方法及其用途 | |
CN104946772B (zh) | 线粒体相关血清微小核糖核酸作为人类肥胖发生的标志物及其应用 | |
Sabe et al. | Preoperative gene expression may be associated with neurocognitive decline after cardiopulmonary bypass | |
CN104630379A (zh) | 非小细胞型肺癌标志物fam107a及其应用 | |
CN105087794A (zh) | 一种检测结核病的试剂盒 | |
CN109295176A (zh) | 用于检测人类结直肠癌braf基因v600e突变的引物、检测方法及试剂盒 | |
Otsuji et al. | Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120704 Assignee: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. Assignor: Hangzhou Adicon Clinical Laboratory Center Co., Ltd. Contract record no.: 2013330000275 Denomination of invention: Reverse transcription-polymerase chain reaction (RT-PCR) primer of human leukemia fusion gene BCR-ABL and application method thereof Granted publication date: 20130724 License type: Exclusive License Record date: 20130823 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20160622 Contract record no.: 2013330000275 Assignee after: Nanchang ADICON Clinical Institute Co Ltd Assignee before: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |